MAPT and early-onset autosomal dominant Alzheimer disease: In a study of >20,000 individuals from Mayo Clinic and the Alzheimer's Disease Genetics Consortium (ADGC), we identified associations with both reduced AD risk and reduced brain MAPT levels with the H2 haplotype.14